Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exo-Top is a South Korean biotechnology company specializing in the isolation and analysis of exosomes for liquid biopsy and diagnostic applications. The company has developed a proprietary platform technology that enables the high-purity extraction of exosomes from various biological fluids, including blood and urine. Their primary focus is on early cancer detection and monitoring through exosomal biomarkers. Exo-Top's technology aims to overcome the limitations of traditional isolation methods like ultracentrifugation, providing a faster and more efficient solution for clinical research and diagnostics. The company currently offers research-use isolation kits and is actively developing a pipeline of cancer-specific diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exo-Top.